154 related articles for article (PubMed ID: 10406155)
1. Survival after malignant tumors of the orbit and periorbit treated by exenteration.
Mouriaux F; Martinot V; Pellerin P; Patenotre P; Rouland JF; Constantinides G
Acta Ophthalmol Scand; 1999 Jun; 77(3):326-30. PubMed ID: 10406155
[TBL] [Abstract][Full Text] [Related]
2. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
Shields CL; Shields JA; Honavar SG; Demirci H
Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
[TBL] [Abstract][Full Text] [Related]
5. Mortality following exenteration for malignant tumours of the orbit.
Rahman I; Maino A; Cook AE; Leatherbarrow B
Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification.
Kwon M; Lee JS; Lee C; Yoon DH; Sa HS
Br J Ophthalmol; 2021 Feb; 105(2):279-284. PubMed ID: 32327417
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic spindle-cell melanoma of the eyelid with orbital invasion.
Dithmar S; Meldrum ML; Murray DR; Grossniklaus HE
Ophthalmic Plast Reconstr Surg; 1999 Mar; 15(2):134-6. PubMed ID: 10189643
[TBL] [Abstract][Full Text] [Related]
8. Orbital exenteration for sinonasal malignancies: indications, rehabilitation and oncologic outcomes.
Vartanian JG; Toledo RN; Bueno T; Kowalski LP
Curr Opin Otolaryngol Head Neck Surg; 2018 Apr; 26(2):122-126. PubMed ID: 29465436
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the sinonasal tract invading the orbit.
Carrau RL; Segas J; Nuss DW; Snyderman CH; Janecka IP; Myers EN; D'Amico F; Johnson JT
Laryngoscope; 1999 Feb; 109(2 Pt 1):230-5. PubMed ID: 10890772
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
11. Adenoid cystic carcinoma of the paranasal sinuses: retrospective series and review of the literature.
Michel G; Joubert M; Delemazure AS; Espitalier F; Durand N; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):257-62. PubMed ID: 23747147
[TBL] [Abstract][Full Text] [Related]
12. Orbital exenteration: The 10-year Massachusetts Eye and Ear Infirmary experience.
Nagendran ST; Lee NG; Fay A; Lefebvre DR; Sutula FC; Freitag SK
Orbit; 2016 Aug; 35(4):199-206. PubMed ID: 27322708
[TBL] [Abstract][Full Text] [Related]
13. [Does orbital exenteration still has a place in 2019?].
Martel A; Hamedani M; Lagier J; Bertolotto C; Gastaud L; Poissonnet G
J Fr Ophtalmol; 2020 Feb; 43(2):152-174. PubMed ID: 31831277
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
15. Orbital exenteration: Institutional review of evolving trends in indications and rehabilitation techniques.
Kiratli H; Koç İ
Orbit; 2018 Jun; 37(3):179-186. PubMed ID: 29039986
[TBL] [Abstract][Full Text] [Related]
16. Malignant conjunctival tumors invading the orbit.
Gökmen Soysal H; Ardiç F
Ophthalmologica; 2008; 222(5):338-43. PubMed ID: 18635931
[TBL] [Abstract][Full Text] [Related]
17. Orbital exenteration in periorbital malignancies.
Roche P; Timon C
Surgeon; 2012 Aug; 10(4):189-93. PubMed ID: 22818275
[TBL] [Abstract][Full Text] [Related]
18. Orbital exenteration: a 10-year experience of a general oncology hospital.
Soysal HG
Orbit; 2010 Jun; 29(3):135-9. PubMed ID: 20497078
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center.
Huang YY; Liang WY; Tsai CC; Kao SC; Yu WK; Kau HC; Liu CJ
Biomed Res Int; 2015; 2015():453091. PubMed ID: 26634208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
